Mar 22, 2017 - Novartis AG (NVS) recently suffered a setback on the announcement of disappointing data from a phase III study, RELAX-AHF-2, on pipeline candidate serelaxin (RLX030).
Mar 22, 2017 - The following slide deck was published by uniQure N.V. in conjunction with this event.
Mar 22, 2017 - Shares of Array BioPharma Inc. (ARRY) slipped 2.30% after the company announced that it has withdrawn its new drug application (NDA) for its pipeline candidate, binimetinib, from the FDA's Division of Oncology Products 2.
Mar 21, 2017 - Let's see if Novartis AG (NVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Mar 21, 2017 - Glaxo carries a Zacks Rank #2 (Buy).
Mar 21, 2017 - Eli Lilly and Company (LLY) recently announced that a phase III combination study evaluating its pipeline candidate abemaciclib in advanced breast cancer, met the primary endpoint of progression-free survival (PFS).
Mar 20, 2017 - Novartis AG (NVS) recently announced results of a new post-hoc analysis from the PARADIGM-HF study on heart failure drug Entresto.
Mar 20, 2017 - Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells DexCom, Aerie Pharmaceuticals, Depomed, Stocks: NBIX,ACRS,FOLD,ANIP,AVXS,GBT,GLPG,AVDL,ACOR,IRTC,C, release date:Mar 20, 2017
Mar 16, 2017 - Conatus Pharmaceuticals Inc. (CNAT) reported fourth-quarter 2016 loss of 35 cents per share, wider than both the Zacks Consensus Estimate of a loss of 32 cents and the year-ago figure of 30 cents.
Mar 16, 2017 - GlaxoSmithKline plc (GSK) announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA seeking approval to expand the label of Fluarix Quadrivalent ??? an influenza vaccine - for infants six months or older.